Top Markets
#1 Prom Prom +36.01%
#2 QuantixAI QuantixAI +31.15%
#3 MowCat MowCat +29.66%
#4 UnifAI Network UnifAI Network +28.77%
#5 GEKKO GEKKO +24.99%
#6 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +20.59%
#7 MarsCoin MarsCoin +19.40%
#8 Kinesis Silver Kinesis Silver +18.57%
#9 Versatize Coin Versatize Coin +16.66%
#10 Derive Derive +15.08%
Coin of the day
Prom Prom
Settings
Language
ENGLISH
Currency
USD
Theme
Captor Therapeutics Spolka Akcyjna Captor Therapeutics Spolka Akcyjna

Captor Therapeutics Spolka Akcyjna

CTX
Rank in Stocks #20482
Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the... Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. Its products in various stages of development include CT-03, which has completed the Phase 1 clinical trials for the treatment of non-small cell lung cancer, triple-negative breast cancer, as well as cancers of the blood, lymphatic system, and bone marrow; and CT-01, which also completed the Phase 1 clinical trials for the treatment of hepatocellular carcinoma, through degradation of oncofetal transcription factor. The company was incorporated in 2015 and is headquartered in Wroclaw, Poland.
Share Price
$20.38
Market Cap
$129.09M
Change (1 day)
-0.82%
Change (1 year)
80.91%
Country
PL
Trade Captor Therapeutics Spolka Akcyjna (CTX)

Category

Healthcare
Number of shares outstanding for Captor Therapeutics Spolka Akcyjna (CTX)
Number of shares outstanding as of August 2026: 0
According to Captor Therapeutics Spolka Akcyjna latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Captor Therapeutics Spolka Akcyjna (CTX) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH